Risk assessment and biosafety recommendations in Belgium

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Diseases

  2021cited by this paper
• OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals

  2014cited by this paper
• Contained use of genetically modified micro-organisms

  2014cited by this paper
• Structure of the β2‐α2 loop and interspecies prion transmission

  2012cited by this paper
• The Risk of Prion Zoonoses

  2012cited by this paper
• Review: Creutzfeldt–Jakob disease: prion protein type, disease phenotype and agent strain

  2012cited by this paper
• Facilitated Cross-Species Transmission of Prions in Extraneural Tissue

  2012cited by this paper
• Decontamination of Prions by the Flowing Afterglow of a Reduced-pressure N2O2 Cold-plasma

  2012cited by this paper
• There Is No Safe Dose of Prions

  2011cited by this paper
• A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay

  2011influential reference
• A Simple, Versatile and Sensitive Cell-Based Assay for Prions from Various Species

  2011cited by this paper
• Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice

  2011cited by this paper
• Fate of prions in soil: a review.

  2011cited by this paper
• Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humans

  2011cited by this paper
• Prion propagation and toxicity in vivo occur in two distinct mechanistic phases

  2011cited by this paper
• Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner.

  2011cited by this paper
• Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

  2011cited by this paper
• Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle

  2011influential reference
• Aerosols

  2011cited by this paper
• Aerosol and nasal transmission of chronic wasting disease in cervidized mice

  2010cited by this paper
• The prion hypothesis: from biological anomaly to basic regulatory mechanism

  2010influential reference
• Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

  2010cited by this paper
• Guideline for Disinfection and Sterilization of Prion-Contaminated Medical Instruments

  2010cited by this paper
• Large‐scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain

  2010cited by this paper
• Faculty Opinions recommendation of The prion protein as a receptor for amyloid-beta.

  2010cited by this paper
• New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment.

  2009cited by this paper
• Detection of protease-resistant cervid prion protein in water from a CWD-endemic area

  2009cited by this paper
• Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey

  2009cited by this paper
• Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material.

  2009cited by this paper
• Risk assessment of laboratories involving the manipulation of unconventional agents causing TSE

  2009cited by this paper
• Inactivation of Animal and Human Prions by Hydrogen Peroxide Gas Plasma Sterilization

  2009cited by this paper
• Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces

  2009cited by this paper
• Recent advances in prion chemotherapeutics.

  2009cited by this paper
• Physiology of the prion protein.

  2008cited by this paper
• Detection and survival of prion agents in aquatic environments.

  2008cited by this paper
• Prion inactivation using a new gaseous hydrogen peroxide sterilisation process.

  2007cited by this paper
• The prion strain phenomenon: molecular basis and unprecedented features.

  2007cited by this paper
• Influence of Water, Fat, and Glycerol on the Mechanism of Thermal Prion Inactivation*

  2007cited by this paper
• Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation

  2007cited by this paper
• A General Model of Prion Strains and Their Pathogenicity

  2007cited by this paper
• Oral Transmissibility of Prion Disease Is Enhanced by Binding to Soil Particles

  2007cited by this paper
• Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 1.

  2006cited by this paper
• Vaccination against prion diseases.

  2006cited by this paper
• Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies

  2006cited by this paper
• Critical factors influencing prion inactivation by sodium hydroxide

  2006cited by this paper
• Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 2.

  2006cited by this paper
• High Incidence of Scrapie Induced by Repeated Injections of Subinfectious Prion Doses

  2005influential reference
• Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases

  2004cited by this paper
• Novel methods for disinfection of prion-contaminated medical devices.

  2004cited by this paper
• Prevalence of lymphoreticular prion protein accumulation in UK tissue samples

  2004cited by this paper
• Prion diseases: infectious and lethal doses following oral challenge.

  2003cited by this paper
• The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects.

  2003cited by this paper
• Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

  2001cited by this paper
• Inactivation of transmissible degenerative encephalopathy agents: A review.

  2000cited by this paper
• Molecular Medicine © 1999 The Picower Institute Press Infectivity of Scrapie Prions Bound to a Stainless

  1999cited by this paper
• Effect of repeated oral infection of hamsters with scrapie.

  1998cited by this paper
• Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide.

  1997cited by this paper
• Prion diseases and the BSE crisis.

  1997cited by this paper
• Survival of scrapie virus after 3 years' interment.

  1991cited by this paper
• Codon 129 changes in the prion protein gene in Caucasians.

  1990cited by this paper
• Reversible chemical modification of the scrapie agent.

  1981cited by this paper
• Does the Agent of Scrapie Replicate without Nucleic Acid ?

  1967cited by this paper
• Self-replication and scrapie.

  1967cited by this paper

• Guía de Patología Autópsica

  2015cites this paper